基于超声、临床和实验室因素的放射组学风险预测模型用于区分桥本甲状腺炎分期
回顾性纳入2018年1月至2023年12月接受确定性手术病理的785例桥本甲状腺炎患者,分为早期和晚期两组,利用超声图像、5项临床和12项实验室指标构建放射组学模型。极端梯度提升(XGBOOST)分类器在训练队列中表现最佳,AUC为0.999(0.998,1),内部测试队列AUC为0.993(0.98,1),第一外部测试队列AUC为0.947(0.866,1),第二外部测试队列AUC为0.98(0.939,1)。超声放射组学特征贡献了模型的78.6%(11/14),其中甲状腺超声横切面一阶特征、纵切面灰度游程矩阵(GLRLM)纹理特征和游离甲状腺素贡献最大。
要点
- XGBOOST模型在训练队列中区分早期与晚期HT的AUC为0.999(0.998,1),内部测试AUC为0.993(0.98,1)。
- 超声放射组学特征贡献了模型的78.6%(11/14),主要特征为横切面一阶特征、纵切面GLRLM纹理特征和游离甲状腺素。
- 模型在两个外部测试队列中AUC分别为0.947(0.866,1)和0.98(0.939,1),显示较好泛化能力。
核心结论
- 研究开发并测试了一种风险预测模型,可有效区分桥本甲状腺炎分期,以便更精准、更主动地在早期阶段管理桥本甲状腺炎患者。
研究设计与样本
- 回顾性收集2018年1月至2023年12月接受确定性手术病理的桥本甲状腺炎患者数据,共纳入785例,分为早期桥本甲状腺炎(单纯抗体阳性或同时伴甲状腺激素升高)和晚期桥本甲状腺炎(抗体阳性并开始出现亚临床甲状腺功能减退或发展为甲状腺功能减退)。获取超声图像及5项临床和12项实验室指标,使用六种分类器构建放射组学模型,采用梯度提升决策树(GBDT)分类器筛选最佳特征,以受试者工作特征(ROC)曲线评估模型性能,并使用一个内部测试队列和两个外部测试队列进行验证。
诊断标准与关键数值
- 极端梯度提升(XGBOOST)在训练队列中AUC为0.999(0.998,1),内部测试队列AUC为0.993(0.98,1),第一外部测试队列AUC为0.947(0.866,1),第二外部测试队列AUC为0.98(0.939,1)。
- 超声放射组学特征贡献了模型的78.6%(11/14)。
- 模型中贡献最大的特征为甲状腺超声横切面一阶特征、纵切面灰度游程矩阵(GLRLM)纹理特征和游离甲状腺素。
临床应用与阅片要点
- 作者认为该模型可有效区分桥本甲状腺炎分期,以便更精准、更主动地在早期阶段管理桥本甲状腺炎患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a radiomics risk-predictive model for differentiating the different stages of Hashimoto's thyroiditis (HT).
METHODS: Data from patients with HT who underwent definitive surgical pathology between January 2018 and December 2023 were retrospectively collected and categorized into early HT (HT patients with simple positive antibodies or simultaneously accompanied by elevated thyroid hormones) and late HT (HT patients with positive antibodies and beginning to present subclinical hypothyroidism or developing hypothyroidism). Ultrasound images and five clinical and 12 laboratory indicators were obtained. Six classifiers were used to construct radiomics models. The gradient boosting decision tree (GBDT) classifier was used to screen for the best features to explore the main risk factors for differentiating early HT. The performance of each model was evaluated by receiver operating characteristic (ROC) curve. The model was validated using one internal and two external test cohorts.
RESULTS: A total of 785 patients were enrolled. Extreme gradient boosting (XGBOOST) showed best performance in the training cohort, with an AUC of 0.999 (0.998, 1), and AUC values of 0.993 (0.98, 1), 0.947 (0.866, 1), and 0.98 (0.939, 1), respectively, in the internal test, first external, and second external cohorts. Ultrasound radiomic features contributed to 78.6% (11/14) of the model. The first-order feature of traverse section of thyroid ultrasound image, texture feature gray-level run length matrix (GLRLM) of longitudinal section of thyroid ultrasound image and free thyroxine showed the greatest contributions in the model.
CONCLUSION: Our study developed and tested a risk-predictive model that effectively differentiated HT stages to more precisely and actively manage patients with HT at an earlier stage.
引用
- Chen JH, Kang K, Wang XY, et al. Development of Radiomics-Based Risk Prediction Models for Stages of Hashimoto's Thyroiditis Using Ultrasound, Clinical, and Laboratory Factors. Ultrasound Med Biol. 2025. PMID: 40545378. doi:10.1016/j.ultrasmedbio.2025.05.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。